Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study of Granix to Disrupt the Bone Marrow Microenvironment in Patients With Multiple Myeloma Undergoing Autologous Stem Cell Transplantation

NCT02112045 is registered in ClinicalTrials.gov with Washington University School of Medicine as lead sponsor.

NCT NCT02112045
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02112045 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study of Granix to Disrupt the Bone Marrow Microenvironment in Patients With Multiple Myeloma Undergoing Autologous Stem Cell Transplantation
Lead sponsor
Washington University School of Medicine
Phase
Phase 2
Overall status
Terminated
Start date
January 20, 2015
Completion date
September 10, 2019
Enrollment
90 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

multiple myeloma